Heparan Sulfate Proteoglycans Initiate Dengue Virus Infection of Hepatocytes
Dengue viruses (DEN) cause a broad spectrum of clinical manifestations including potentially life-threatening conditions such as hemorrhagic shock syndrome and less frequently acute hepatitis with liver failure and encephalopathy. In addition, dengue viruses provide a potential model to understand t...
Gespeichert in:
Veröffentlicht in: | Hepatology (Baltimore, Md.) Md.), 2000-11, Vol.32 (5), p.1069-1077 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1077 |
---|---|
container_issue | 5 |
container_start_page | 1069 |
container_title | Hepatology (Baltimore, Md.) |
container_volume | 32 |
creator | Hilgard, Philip Stockert, Richard |
description | Dengue viruses (DEN) cause a broad spectrum of clinical manifestations including potentially life-threatening conditions such as hemorrhagic shock syndrome and less frequently acute hepatitis with liver failure and encephalopathy. In addition, dengue viruses provide a potential model to understand the initiation of hepatocyte infection by the structurally closely related hepatitis C virus (HCV), because this virus at present cannot be grown in cell culture. Although the initial steps of viral infection are a critical determinant of tissue tropism and therefore pathogenesis, little is known about the molecular basis of binding and endocytic trafficking of DEN or of any other flavivirus. Our studies revealed that binding of radiolabeled DEN to the human hepatoma cell line HuH-7 was strictly pH dependent and substantially inhibitable by the glycosaminoglycan heparin. Ligand-blot analysis, performed as a viral overlay assay, showed two heparan sulfate (HS) containing cell-surface binding proteins resolving at 33 and 37 kd. Based on the sensitivity of unprotected virus and the viral binding site on the cell surface to trypsin, viral internalization was quantified as an increase in trypsin protected virus over time. Virus trafficking to the site of degradation was inhibited by pH dissociation of the clathrin coat and dependent on IP
3 -mediated homotypic endosomal fusion. These findings confirm the hypothesis that binding and internalization of DEN by hepatocytes are mediated primarily by HS containing proteoglycans and suggest that flaviviruses traffic the major clathrin-dependent endocytic pathway during infection.
(Hepatology 2000;32:1069-1077.) |
doi_str_mv | 10.1053/jhep.2000.18713 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72358295</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0270913900714820</els_id><sourcerecordid>72358295</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5285-2a6c697bf705e524f3cc727450908b870225c2fddc486ead6ae4a8057720cf3</originalsourceid><addsrcrecordid>eNqFkE1LxDAQhoMoun6cvUlB8FadJs0mPYqurrCgoHgN2XSikW6zJq2y_97UXfQknoYMz_tOeAg5LuC8AM4u3l5xeU4B0lOKgm2RUcGpyBnjsE1GQAXkVcGqPbIf41vCqpLKXbJXpDAAlyMym-JSB91mj31jdYfZQ_Ad-pdmZXQbs7vWdW5YX2P70mP27EI_bC2azvk28zYbCjpvVh3GQ7JjdRPxaDMPyOPN5Olqms_ub--uLme54VTynOqxGVdibgVw5LS0zBhBRcmhAjmXAijlhtq6NqUco67HGkstgQtBwVh2QM7Wrcvg33uMnVq4aLBpdIu-j0pQxiWteAIv1qAJPsaAVi2DW-iwUgWoQZ8a9KlBn_rWlxInm-p-vsD6l9_4SsDpBtDR6MYmc8bFH06CYKxKVLWmPl2Dq_-uqunkgRfAKHDKf7OYBH44DCoah63B2oUkXdXe_fn9L2AlnBQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72358295</pqid></control><display><type>article</type><title>Heparan Sulfate Proteoglycans Initiate Dengue Virus Infection of Hepatocytes</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Hilgard, Philip ; Stockert, Richard</creator><creatorcontrib>Hilgard, Philip ; Stockert, Richard</creatorcontrib><description>Dengue viruses (DEN) cause a broad spectrum of clinical manifestations including potentially life-threatening conditions such as hemorrhagic shock syndrome and less frequently acute hepatitis with liver failure and encephalopathy. In addition, dengue viruses provide a potential model to understand the initiation of hepatocyte infection by the structurally closely related hepatitis C virus (HCV), because this virus at present cannot be grown in cell culture. Although the initial steps of viral infection are a critical determinant of tissue tropism and therefore pathogenesis, little is known about the molecular basis of binding and endocytic trafficking of DEN or of any other flavivirus. Our studies revealed that binding of radiolabeled DEN to the human hepatoma cell line HuH-7 was strictly pH dependent and substantially inhibitable by the glycosaminoglycan heparin. Ligand-blot analysis, performed as a viral overlay assay, showed two heparan sulfate (HS) containing cell-surface binding proteins resolving at 33 and 37 kd. Based on the sensitivity of unprotected virus and the viral binding site on the cell surface to trypsin, viral internalization was quantified as an increase in trypsin protected virus over time. Virus trafficking to the site of degradation was inhibited by pH dissociation of the clathrin coat and dependent on IP
3 -mediated homotypic endosomal fusion. These findings confirm the hypothesis that binding and internalization of DEN by hepatocytes are mediated primarily by HS containing proteoglycans and suggest that flaviviruses traffic the major clathrin-dependent endocytic pathway during infection.
(Hepatology 2000;32:1069-1077.)</description><identifier>ISSN: 0270-9139</identifier><identifier>EISSN: 1527-3350</identifier><identifier>DOI: 10.1053/jhep.2000.18713</identifier><identifier>PMID: 11050058</identifier><identifier>CODEN: HPTLD9</identifier><language>eng</language><publisher>Philadelphia, PA: Elsevier Inc</publisher><subject>Arboviroses ; Biological and medical sciences ; Carrier Proteins - metabolism ; Dengue - physiopathology ; Dengue fevers ; Dengue Virus - drug effects ; Dengue Virus - physiology ; Glycosaminoglycans - metabolism ; Glycosaminoglycans - pharmacology ; Glycosylation ; Heparan Sulfate Proteoglycans - physiology ; Heparin - pharmacology ; Hepatocytes - metabolism ; Hepatocytes - virology ; Human viral diseases ; Humans ; Hydrogen-Ion Concentration ; Infectious diseases ; Intracellular Membranes - metabolism ; Lyases - pharmacology ; Medical sciences ; Sulfates - metabolism ; Tropical viral diseases ; Trypsin - pharmacology ; Tumor Cells, Cultured ; Viral diseases ; Viral Envelope Proteins - physiology ; Viral Proteins - metabolism</subject><ispartof>Hepatology (Baltimore, Md.), 2000-11, Vol.32 (5), p.1069-1077</ispartof><rights>2000 The American Association for the Study of Liver Diseases</rights><rights>Copyright © 2000 American Association for the Study of Liver Diseases</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5285-2a6c697bf705e524f3cc727450908b870225c2fddc486ead6ae4a8057720cf3</citedby><cites>FETCH-LOGICAL-c5285-2a6c697bf705e524f3cc727450908b870225c2fddc486ead6ae4a8057720cf3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1053%2Fjhep.2000.18713$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1053%2Fjhep.2000.18713$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=807339$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11050058$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hilgard, Philip</creatorcontrib><creatorcontrib>Stockert, Richard</creatorcontrib><title>Heparan Sulfate Proteoglycans Initiate Dengue Virus Infection of Hepatocytes</title><title>Hepatology (Baltimore, Md.)</title><addtitle>Hepatology</addtitle><description>Dengue viruses (DEN) cause a broad spectrum of clinical manifestations including potentially life-threatening conditions such as hemorrhagic shock syndrome and less frequently acute hepatitis with liver failure and encephalopathy. In addition, dengue viruses provide a potential model to understand the initiation of hepatocyte infection by the structurally closely related hepatitis C virus (HCV), because this virus at present cannot be grown in cell culture. Although the initial steps of viral infection are a critical determinant of tissue tropism and therefore pathogenesis, little is known about the molecular basis of binding and endocytic trafficking of DEN or of any other flavivirus. Our studies revealed that binding of radiolabeled DEN to the human hepatoma cell line HuH-7 was strictly pH dependent and substantially inhibitable by the glycosaminoglycan heparin. Ligand-blot analysis, performed as a viral overlay assay, showed two heparan sulfate (HS) containing cell-surface binding proteins resolving at 33 and 37 kd. Based on the sensitivity of unprotected virus and the viral binding site on the cell surface to trypsin, viral internalization was quantified as an increase in trypsin protected virus over time. Virus trafficking to the site of degradation was inhibited by pH dissociation of the clathrin coat and dependent on IP
3 -mediated homotypic endosomal fusion. These findings confirm the hypothesis that binding and internalization of DEN by hepatocytes are mediated primarily by HS containing proteoglycans and suggest that flaviviruses traffic the major clathrin-dependent endocytic pathway during infection.
(Hepatology 2000;32:1069-1077.)</description><subject>Arboviroses</subject><subject>Biological and medical sciences</subject><subject>Carrier Proteins - metabolism</subject><subject>Dengue - physiopathology</subject><subject>Dengue fevers</subject><subject>Dengue Virus - drug effects</subject><subject>Dengue Virus - physiology</subject><subject>Glycosaminoglycans - metabolism</subject><subject>Glycosaminoglycans - pharmacology</subject><subject>Glycosylation</subject><subject>Heparan Sulfate Proteoglycans - physiology</subject><subject>Heparin - pharmacology</subject><subject>Hepatocytes - metabolism</subject><subject>Hepatocytes - virology</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Hydrogen-Ion Concentration</subject><subject>Infectious diseases</subject><subject>Intracellular Membranes - metabolism</subject><subject>Lyases - pharmacology</subject><subject>Medical sciences</subject><subject>Sulfates - metabolism</subject><subject>Tropical viral diseases</subject><subject>Trypsin - pharmacology</subject><subject>Tumor Cells, Cultured</subject><subject>Viral diseases</subject><subject>Viral Envelope Proteins - physiology</subject><subject>Viral Proteins - metabolism</subject><issn>0270-9139</issn><issn>1527-3350</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1LxDAQhoMoun6cvUlB8FadJs0mPYqurrCgoHgN2XSikW6zJq2y_97UXfQknoYMz_tOeAg5LuC8AM4u3l5xeU4B0lOKgm2RUcGpyBnjsE1GQAXkVcGqPbIf41vCqpLKXbJXpDAAlyMym-JSB91mj31jdYfZQ_Ad-pdmZXQbs7vWdW5YX2P70mP27EI_bC2azvk28zYbCjpvVh3GQ7JjdRPxaDMPyOPN5Olqms_ub--uLme54VTynOqxGVdibgVw5LS0zBhBRcmhAjmXAijlhtq6NqUco67HGkstgQtBwVh2QM7Wrcvg33uMnVq4aLBpdIu-j0pQxiWteAIv1qAJPsaAVi2DW-iwUgWoQZ8a9KlBn_rWlxInm-p-vsD6l9_4SsDpBtDR6MYmc8bFH06CYKxKVLWmPl2Dq_-uqunkgRfAKHDKf7OYBH44DCoah63B2oUkXdXe_fn9L2AlnBQ</recordid><startdate>200011</startdate><enddate>200011</enddate><creator>Hilgard, Philip</creator><creator>Stockert, Richard</creator><general>Elsevier Inc</general><general>W.B. Saunders</general><general>Wiley</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200011</creationdate><title>Heparan Sulfate Proteoglycans Initiate Dengue Virus Infection of Hepatocytes</title><author>Hilgard, Philip ; Stockert, Richard</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5285-2a6c697bf705e524f3cc727450908b870225c2fddc486ead6ae4a8057720cf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Arboviroses</topic><topic>Biological and medical sciences</topic><topic>Carrier Proteins - metabolism</topic><topic>Dengue - physiopathology</topic><topic>Dengue fevers</topic><topic>Dengue Virus - drug effects</topic><topic>Dengue Virus - physiology</topic><topic>Glycosaminoglycans - metabolism</topic><topic>Glycosaminoglycans - pharmacology</topic><topic>Glycosylation</topic><topic>Heparan Sulfate Proteoglycans - physiology</topic><topic>Heparin - pharmacology</topic><topic>Hepatocytes - metabolism</topic><topic>Hepatocytes - virology</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Hydrogen-Ion Concentration</topic><topic>Infectious diseases</topic><topic>Intracellular Membranes - metabolism</topic><topic>Lyases - pharmacology</topic><topic>Medical sciences</topic><topic>Sulfates - metabolism</topic><topic>Tropical viral diseases</topic><topic>Trypsin - pharmacology</topic><topic>Tumor Cells, Cultured</topic><topic>Viral diseases</topic><topic>Viral Envelope Proteins - physiology</topic><topic>Viral Proteins - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hilgard, Philip</creatorcontrib><creatorcontrib>Stockert, Richard</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Hepatology (Baltimore, Md.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hilgard, Philip</au><au>Stockert, Richard</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Heparan Sulfate Proteoglycans Initiate Dengue Virus Infection of Hepatocytes</atitle><jtitle>Hepatology (Baltimore, Md.)</jtitle><addtitle>Hepatology</addtitle><date>2000-11</date><risdate>2000</risdate><volume>32</volume><issue>5</issue><spage>1069</spage><epage>1077</epage><pages>1069-1077</pages><issn>0270-9139</issn><eissn>1527-3350</eissn><coden>HPTLD9</coden><abstract>Dengue viruses (DEN) cause a broad spectrum of clinical manifestations including potentially life-threatening conditions such as hemorrhagic shock syndrome and less frequently acute hepatitis with liver failure and encephalopathy. In addition, dengue viruses provide a potential model to understand the initiation of hepatocyte infection by the structurally closely related hepatitis C virus (HCV), because this virus at present cannot be grown in cell culture. Although the initial steps of viral infection are a critical determinant of tissue tropism and therefore pathogenesis, little is known about the molecular basis of binding and endocytic trafficking of DEN or of any other flavivirus. Our studies revealed that binding of radiolabeled DEN to the human hepatoma cell line HuH-7 was strictly pH dependent and substantially inhibitable by the glycosaminoglycan heparin. Ligand-blot analysis, performed as a viral overlay assay, showed two heparan sulfate (HS) containing cell-surface binding proteins resolving at 33 and 37 kd. Based on the sensitivity of unprotected virus and the viral binding site on the cell surface to trypsin, viral internalization was quantified as an increase in trypsin protected virus over time. Virus trafficking to the site of degradation was inhibited by pH dissociation of the clathrin coat and dependent on IP
3 -mediated homotypic endosomal fusion. These findings confirm the hypothesis that binding and internalization of DEN by hepatocytes are mediated primarily by HS containing proteoglycans and suggest that flaviviruses traffic the major clathrin-dependent endocytic pathway during infection.
(Hepatology 2000;32:1069-1077.)</abstract><cop>Philadelphia, PA</cop><pub>Elsevier Inc</pub><pmid>11050058</pmid><doi>10.1053/jhep.2000.18713</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0270-9139 |
ispartof | Hepatology (Baltimore, Md.), 2000-11, Vol.32 (5), p.1069-1077 |
issn | 0270-9139 1527-3350 |
language | eng |
recordid | cdi_proquest_miscellaneous_72358295 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete; EZB-FREE-00999 freely available EZB journals |
subjects | Arboviroses Biological and medical sciences Carrier Proteins - metabolism Dengue - physiopathology Dengue fevers Dengue Virus - drug effects Dengue Virus - physiology Glycosaminoglycans - metabolism Glycosaminoglycans - pharmacology Glycosylation Heparan Sulfate Proteoglycans - physiology Heparin - pharmacology Hepatocytes - metabolism Hepatocytes - virology Human viral diseases Humans Hydrogen-Ion Concentration Infectious diseases Intracellular Membranes - metabolism Lyases - pharmacology Medical sciences Sulfates - metabolism Tropical viral diseases Trypsin - pharmacology Tumor Cells, Cultured Viral diseases Viral Envelope Proteins - physiology Viral Proteins - metabolism |
title | Heparan Sulfate Proteoglycans Initiate Dengue Virus Infection of Hepatocytes |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T13%3A21%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Heparan%20Sulfate%20Proteoglycans%20Initiate%20Dengue%20Virus%20Infection%20of%20Hepatocytes&rft.jtitle=Hepatology%20(Baltimore,%20Md.)&rft.au=Hilgard,%20Philip&rft.date=2000-11&rft.volume=32&rft.issue=5&rft.spage=1069&rft.epage=1077&rft.pages=1069-1077&rft.issn=0270-9139&rft.eissn=1527-3350&rft.coden=HPTLD9&rft_id=info:doi/10.1053/jhep.2000.18713&rft_dat=%3Cproquest_cross%3E72358295%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72358295&rft_id=info:pmid/11050058&rft_els_id=S0270913900714820&rfr_iscdi=true |